Design of modular non-viral gene therapy vectors
- PMID: 16243391
- PMCID: PMC2648393
- DOI: 10.1016/j.biomaterials.2005.09.036
Design of modular non-viral gene therapy vectors
Abstract
Gene delivery has numerous potential applications both clinically and for basic science research. Non-viral vectors represent the long-term future of gene therapy and biomaterials are a critical component for the development of efficient delivery systems. Biomaterial development combined with fundamental studies of virus function and cellular processes will enable the molecular level design of modular vectors. Vectors are being developed based on cationic polymers or lipids that contain functional groups to mediate appropriate interactions with the extracellular environment or to interface with specific cellular processes. This review describes recent progress on the development of biomaterials for non-viral vectors and highlights opportunities for future development. Ultimately, efficient vectors will expand the traditional applications of gene therapy within the clinic and may enable numerous other opportunities within diagnostics, biotechnology, and basic science research.
Figures
References
-
- Ziauddin J, Sabatini DM. Microarrays of cells expressing defined cDNAs. Nature. 2001;411(6833):107–110. - PubMed
-
- Boulanger C, Di Giorgio C, Gaucheron J, Vierling P. Transfection with fluorinated lipoplexes based on new fluorinated cationic lipids and in the presence of a bile salt surfactant. Bioconjug Chem. 2004;15(4):901–908. - PubMed
-
- Segura T, Shea LD. Materials for non-viral gene delivery. Annu Rev Mater Res. 2001;31:25–46.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
